Model
Edge
Alnylam Pharmaceuticals, Inc.
0001829252
Filing Type
144
Filing Date
3/2/2026
Updated
3/3/26, 2:11 PM
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities